Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 11-2023 | 08-2023 | 05-2023 | 02-2023 | 11-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,954 | 1,352 | 3,164 | 3,272 | 4,533 |
| Marketable Securities | 72 | 126 | 270 | 268 | 270 |
| Receivables | 535 | 175 | 172 | 137 | 286 |
| Inventories | N/A | 0 | 0 | 8 | 10 |
| TOTAL | $2,694 | $2,200 | $4,235 | $4,004 | $5,359 |
| Non-Current Assets | |||||
| PPE Net | 390 | 422 | 455 | 333 | 354 |
| Intangibles | 494 | 463 | 549 | 518 | 501 |
| Other Non-Current Assets | 49 | 0 | 0 | 0 | 0 |
| TOTAL | $933 | $884 | $1,004 | $851 | $854 |
| Total Assets | $3,627 | $3,084 | $5,240 | $4,855 | $6,213 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 92 | 225 | 1,011 | 180 | 231 |
| TOTAL | $125 | $268 | $1,056 | $223 | $282 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 4 | N/A |
| Other Non-Current Liabilities | 370 | 364 | 354 | 342 | 330 |
| TOTAL | $130 | $136 | $143 | $0 | $0 |
| Total Liabilities | $254 | $404 | $1,198 | $223 | $282 |
| Shareholders' Equity | |||||
| Common Shares | 10 | 8 | 8 | 6 | 6 |
| Retained earnings | -46,943 | -45,763 | -44,524 | -42,153 | -40,854 |
| Other shareholders' equity | 4 | 0 | 0 | 0 | 0 |
| TOTAL | $3,742 | $3,044 | $4,395 | $4,974 | $6,262 |
| Total Liabilities And Equity | $3,997 | $3,448 | $5,594 | $5,197 | $6,543 |